ATE269296T1 - Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf - Google Patents

Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf

Info

Publication number: ATE269296T1
Authority: AT; Austria
Prior art keywords: inhibitors; human; production; acid derivatives; hydroxamic acid
Prior art date: 1998-06-22

Application number

AT99928068T

Other languages

English (en)

Inventor

Andrew Faller

David T Macpherson

Peter H Milner

Jayshree Mistry

John Gerard Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-22

Filing date

1999-06-22

Publication date

2004-07-15

1999-06-22 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE269296T1 publication Critical patent/ATE269296T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

AT99928068T 1998-06-22 1999-06-22 Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf ATE269296T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9813451.3A GB9813451D0 (en)	1998-06-22	1998-06-22	Novel compounds
PCT/GB1999/001954 WO1999067201A1 (en)	1998-06-22	1999-06-22	Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release

Publications (1)

Publication Number	Publication Date
ATE269296T1 true ATE269296T1 (de)	2004-07-15

Family

ID=10834177

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99928068T ATE269296T1 (de)	1998-06-22	1999-06-22	Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf

Country Status (32)

Country	Link
US (1)	US6458779B1 (de)
EP (1)	EP1089963B1 (de)
JP (1)	JP2002518470A (de)
KR (1)	KR20010053076A (de)
CN (1)	CN1306508A (de)
AP (1)	AP2000002001A0 (de)
AR (1)	AR029303A1 (de)
AT (1)	ATE269296T1 (de)
AU (1)	AU744801B2 (de)
BG (1)	BG105154A (de)
BR (1)	BR9911423A (de)
CA (1)	CA2335513A1 (de)
DE (1)	DE69918113T2 (de)
DK (1)	DK1089963T3 (de)
EA (1)	EA200100065A1 (de)
ES (1)	ES2222711T3 (de)
GB (1)	GB9813451D0 (de)
HK (1)	HK1025894A1 (de)
HU (1)	HUP0102776A3 (de)
ID (1)	ID27413A (de)
IL (1)	IL139738A (de)
MY (1)	MY121785A (de)
NO (1)	NO20006349D0 (de)
NZ (1)	NZ508229A (de)
OA (1)	OA11639A (de)
PL (1)	PL345038A1 (de)
PT (1)	PT1089963E (de)
SI (1)	SI1089963T1 (de)
SK (1)	SK19562000A3 (de)
TR (1)	TR200003877T2 (de)
WO (1)	WO1999067201A1 (de)
ZA (1)	ZA200007254B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020082200A1 (en) *	1994-07-13	2002-06-27	Smithkline Beecham P.1.C.	Use of inhibitors of human S-CD23
AU3979200A (en) *	1999-04-09	2000-11-14	British Biotech Pharmaceuticals Limited	Antimicrobial agents
GB9925470D0 (en) *	1999-10-27	1999-12-29	Smithkline Beecham Plc	Novel compounds
GB9929527D0 (en) *	1999-12-14	2000-02-09	Smithkline Beecham Plc	Novel compounds
US20030134880A1 (en) *	2000-02-24	2003-07-17	Gordon Bruton	Novel cd23 inhibitors
WO2004076386A2 (en)	2003-02-25	2004-09-10	Topotarget Uk Limited	Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9223904D0 (en) *	1992-11-13	1993-01-06	British Bio Technology	Inhibition of cytokine production
GB9414157D0 (en)	1994-07-13	1994-08-31	Smithkline Beecham Plc	Medical use
GB9507799D0 (en) *	1995-04-18	1995-05-31	British Biotech Pharm	Metalloproteinase inhibitors
US5691381A (en)	1995-04-18	1997-11-25	The Dupont Merck Pharmaceutical Company	Hydroxamic and carbocyclic acids as metalloprotease inhibitors
GB9513331D0 (en) *	1995-06-30	1995-09-06	British Biotech Pharm	Matrix metalloproteinase inhibitors
WO1997015553A1 (fr) *	1995-10-23	1997-05-01	Sankyo Company, Limited	Derives de l'acide hydroxamique
GB9609794D0 (en) *	1996-05-10	1996-07-17	Smithkline Beecham Plc	Novel compounds
US6251913B1 (en) *	1997-03-28	2001-06-26	Zeneca Limited	Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor

1998
- 1998-06-22 GB GBGB9813451.3A patent/GB9813451D0/en not_active Ceased
1999
- 1999-06-22 IL IL13973899A patent/IL139738A/en not_active IP Right Cessation
- 1999-06-22 KR KR1020007014549A patent/KR20010053076A/ko not_active Application Discontinuation
- 1999-06-22 HU HU0102776A patent/HUP0102776A3/hu unknown
- 1999-06-22 OA OA1200000359A patent/OA11639A/en unknown
- 1999-06-22 EA EA200100065A patent/EA200100065A1/ru unknown
- 1999-06-22 AP APAP/P/2000/002001A patent/AP2000002001A0/en unknown
- 1999-06-22 DE DE69918113T patent/DE69918113T2/de not_active Expired - Fee Related
- 1999-06-22 TR TR2000/03877T patent/TR200003877T2/xx unknown
- 1999-06-22 ES ES99928068T patent/ES2222711T3/es not_active Expired - Lifetime
- 1999-06-22 MY MYPI99002571A patent/MY121785A/en unknown
- 1999-06-22 PL PL99345038A patent/PL345038A1/xx not_active Application Discontinuation
- 1999-06-22 NZ NZ508229A patent/NZ508229A/en unknown
- 1999-06-22 SI SI9930648T patent/SI1089963T1/xx unknown
- 1999-06-22 SK SK1956-2000A patent/SK19562000A3/sk unknown
- 1999-06-22 CA CA002335513A patent/CA2335513A1/en not_active Abandoned
- 1999-06-22 WO PCT/GB1999/001954 patent/WO1999067201A1/en not_active Application Discontinuation
- 1999-06-22 DK DK99928068T patent/DK1089963T3/da active
- 1999-06-22 PT PT99928068T patent/PT1089963E/pt unknown
- 1999-06-22 EP EP99928068A patent/EP1089963B1/de not_active Expired - Lifetime
- 1999-06-22 BR BR9911423-2A patent/BR9911423A/pt not_active IP Right Cessation
- 1999-06-22 US US09/701,946 patent/US6458779B1/en not_active Expired - Fee Related
- 1999-06-22 AT AT99928068T patent/ATE269296T1/de not_active IP Right Cessation
- 1999-06-22 JP JP2000555856A patent/JP2002518470A/ja active Pending
- 1999-06-22 AU AU45195/99A patent/AU744801B2/en not_active Ceased
- 1999-06-22 ID IDW20002683A patent/ID27413A/id unknown
- 1999-06-22 CN CN99807653A patent/CN1306508A/zh active Pending
- 1999-06-22 AR ARP990102994A patent/AR029303A1/es unknown
2000
- 2000-12-07 ZA ZA200007254A patent/ZA200007254B/en unknown
- 2000-12-13 NO NO20006349A patent/NO20006349D0/no not_active Application Discontinuation
2001
- 2001-01-15 BG BG105154A patent/BG105154A/bg unknown
- 2001-09-14 HK HK01106515A patent/HK1025894A1/xx unknown

Also Published As

Publication number	Publication date
ID27413A (id)	2001-04-05
BG105154A (bg)	2001-08-31
HK1025894A1 (en)	2000-12-01
KR20010053076A (ko)	2001-06-25
ZA200007254B (en)	2002-02-07
EA200100065A1 (ru)	2001-06-25
NZ508229A (en)	2003-12-19
HUP0102776A3 (en)	2002-11-28
CA2335513A1 (en)	1999-12-29
NO20006349L (no)	2000-12-13
EP1089963B1 (de)	2004-06-16
US6458779B1 (en)	2002-10-01
CN1306508A (zh)	2001-08-01
GB9813451D0 (en)	1998-08-19
BR9911423A (pt)	2001-03-13
ES2222711T3 (es)	2005-02-01
DK1089963T3 (da)	2004-10-18
SK19562000A3 (sk)	2001-08-06
IL139738A (en)	2005-12-18
IL139738A0 (en)	2002-02-10
AP2000002001A0 (en)	2000-12-31
PT1089963E (pt)	2004-10-29
TR200003877T2 (tr)	2001-06-21
PL345038A1 (en)	2001-11-19
DE69918113D1 (de)	2004-07-22
EP1089963A1 (de)	2001-04-11
AU744801B2 (en)	2002-03-07
OA11639A (en)	2004-11-27
AU4519599A (en)	2000-01-10
MY121785A (en)	2006-02-28
JP2002518470A (ja)	2002-06-25
NO20006349D0 (no)	2000-12-13
SI1089963T1 (en)	2004-12-31
WO1999067201A1 (en)	1999-12-29
DE69918113T2 (de)	2005-07-07
AR029303A1 (es)	2003-06-25
HUP0102776A2 (hu)	2001-12-28

Legal Events

Date

Code

Title

Description

2004-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1089963

Country of ref document: EP

2007-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE198326T1 (de)	2001-01-15	Arylsulfonamido-substituierte hydroxamsäure derivate als inhibitoren von mmp und tnf
DE59703869D1 (de)	2001-07-26	Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
DE69826662D1 (de)	2004-11-04	4-brom or 4-iod-phenylamino-benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
EP1507756A4 (de)	2006-03-15	Ccr9-inhibitoren und verfahren zu deren verwendung
IS6899A (is)	2003-07-30	Samsetning og andveiruvirkni tengdra azaindóloxóediksýru píperazín afleiða
ATE306487T1 (de)	2005-10-15	Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha
IS7682A (is)	2005-02-01	Samsetning og andveiruvirkni skiptitengdra azaindóloxóediksýru píperazín afleiðna
DE69927969D1 (de)	2005-12-01	Kontrollierte freisetzung von liponsäure
ATE421954T1 (de)	2009-02-15	Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
DE69930619D1 (de)	2006-05-18	Verwendung von rosmarinsäure und deren derivate als immunsuppressor oder als inhibitor von sh-2 vermittelten prozessen
DE69511240D1 (de)	1999-09-09	Derivate des hydroxamsäure als metalloproteinaseinhibitoren
ATE246673T1 (de)	2003-08-15	Inhibitoren der produktion von s-cd23 und der secretion von tnf
IL147774A0 (en)	2002-08-14	Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production
IS5990A (is)	2001-07-05	Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar
AU2002348474A1 (en)	2003-04-28	Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
ATE269296T1 (de)	2004-07-15	Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf
PL364171A1 (en)	2004-12-13	Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
HK1045260B (zh)	2005-06-10	15-羥基二十碳四烯酸雜原子阻斷類似物及其使用方法
DK1228026T3 (da)	2004-04-05	15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
ATE284382T1 (de)	2004-12-15	Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23
DK1228027T3 (da)	2004-07-19	3-heteroatomsubstituerede og to carbonhomologe af 15-HETE og fremgangsmåder til anvendelse
PT1230227E (pt)	2004-10-29	Sulamatos de benzole e benzotiazole e sua utilizacao como inibidores de sulfatase
ATE302023T1 (de)	2005-09-15	Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
DE60336549D1 (de)	2011-05-12	Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure
AU1872001A (en)	2001-06-25	Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release